Abstract
A Single Center Experience of Central Nervous System Manifestations of Graft Versus Host Disease
Transplantation and cellular therapy, Vol.30(2 Suppl), pp.S288-S289
02/2024
DOI: 10.1016/j.jtct.2023.12.391
Abstract
Central nervous system (CNS) involvement of graft versus host disease (GvHD) is a rare cause of CNS disorders after allogeneic hematopoietic stem cell transplantation (Allo-HSCT). CNS GvHD symptoms are heterogeneous and include cerebrovascular manifestations, demyelinating disease and immune-mediated encephalitis. The 2010 consensus conference on GVHD provided a framework to diagnose this syndrome (1)
Cases: We report 8 cases of possible CNS-GVHD from our center. Table 1 summarizes key transplant related characteristics while Table 2 summarizes neurological features of the cases. Altered mental status due to encephalopathy was the most common presentation with a lesser incidence of seizure, hemiparesis, altered higher mental functions as well as cerebellar dysfunction. 6 amongst these had histological evidence of immune-mediated pathological process. Only one case could be diagnosed as definite CNS GvHD as per 2010 guidelines while one more could be diagnosed as probable. Out of the 7 cases who were treated with immunosuppression, 4 showed a partial response. Only two of the cases showed long term survival (>1 year) after the onset of CNS-GvHD.
CNS-related GvHD is a rare cause of CNS disorders after Allo-HSCT and is associated with a poor prognosis. The diagnosis of CNS-GvHD by the 2010 consensus criteria is based on rigid criteria and does not cover a majority of cases with strong clinical suspicion.
Details
- Title: Subtitle
- A Single Center Experience of Central Nervous System Manifestations of Graft Versus Host Disease
- Creators
- Niranjan S Khaire - Princess Margaret Cancer CentreSunu Cyriac - Amala Institute of Medical SciencesRam Vasudevan Nampoothiri - Ottawa HospitalArmin Gerbitz - Princess Margaret Cancer CentreDennis (Dong Hwan) Kim - Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Centre, Toronto, ON, CanadaRajat Kumar - Princess Margaret Cancer CentreWilson Lam - Princess Margaret Cancer CentreArjun D. Law - Princess Margaret Cancer CentreJeffrey H Lipton - Princess Margaret Cancer CentreIvan Pasic - Princess Margaret Cancer CentreFotios V. Michelis - Princess Margaret Cancer CentreIgor Novitzky-Basso - Princess Margaret Cancer CentreJonas Mattsson - Princess Margaret Cancer CentreAuro Viswabandya - Princess Margaret Cancer Centre
- Resource Type
- Abstract
- Publication Details
- Transplantation and cellular therapy, Vol.30(2 Suppl), pp.S288-S289
- DOI
- 10.1016/j.jtct.2023.12.391
- ISSN
- 2666-6367
- eISSN
- 2666-6367
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 02/2024
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985240981802771
Metrics
1 Record Views